Google’s Manipulated Ad Auctions, Microsoft Buys Activision Blizzard, and the Danger of Billionaires

Pivot

Vox Media Podcast Network

News Commentary, News, Technology, Tech News

4.3 • 7.6K Ratings

🗓️ 19 January 2022

⏱️ 67 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Kara and Scott discuss Microsoft's play for Activision Blizzard, Google's alleged ad auction shell game, and Peleton's rise in prices. Also, DirecTV is dropping One America News. We’re joined by our Friend of Pivot, Peter S. Goodman to discuss his book, “DAVOS MAN: How the Billionaires Devoured the World.” You can find Peter on Twitter at @petersgoodman. Send us your Listener Mail questions, via Yappa, at nymag.com/pivot. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	This episode of Pivot is brought to you by Saks.com.
0:05.1	If you haven't taken care of your holiday shopping at Don't Panic, Saks.com has everything
0:09.4	you need to get this done right.
0:10.4	Their new holiday gift got is loaded with great gift ideas curated by the Saks.com editors.
0:16.5	There's truly something for everyone from La Mer skin care sets handpicked by the beauty
0:20.1	team to cozy Montclair beanies.
0:22.0	Plus, if you need a hand, you can even reach out to the Saks digital stylist for free personalized
0:26.8	gift recommendations. Plus, free shipping, free returns every day at Saks.com. I use
0:31.8	Saks.com. I think they do a wonderful job. It's not about what they have. It's about what
0:35.7	they don't have. I know that anything I look at, I think, you know, I like this.
0:45.2	Support for this podcast comes from Regeneron. Regeneron is a leading biotechnology company
0:50.4	that invents life transforming medicines for people with serious diseases. Their team of
0:55.6	scientists and science supporters seeks to accelerate and improve the traditional drug
1:00.2	development process through homegrown bottleneck breaking technologies and a one-of-a-kind genetic
1:05.9	research group. Now Regeneron is expanding their industry leading antibody medicine capabilities
1:12.0	and perfecting new approaches like gene editing and engineering to spark the future of
1:16.9	Genetics Medicine. Discover how Regeneron is staying on the cutting edge of science to
1:22.1	build the medicines of tomorrow at cspecacularscience.com.
1:32.8	Hi everyone, this is Pivot from New York Magazine in the Vox Media Podcast Network. I'm
1:36.8	Cara Swisher.
1:37.8	And I'm Scott Galaway.
1:39.2	How you doing, Scott?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vox Media Podcast Network, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vox Media Podcast Network and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.